We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

54 hedge funds and large institutions have $443M invested in RAPT Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 4

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

77% more capital invested

Capital invested by funds: $250M → $443M (+$192M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

42% more funds holding

Funds holding: 38 → 54 (+16)

1.65% more ownership

Funds ownership: 6.06% → 7.71% (+1.6%)

Holders
54
Holders Change
+16
Holders Change %
+42.11%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
20
Increased
24
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ROTUOC
Regents of the University of California
California
+$30.4M
2
BlackRock
BlackRock
New York
+$11.7M
3
Squarepoint
Squarepoint
New York
+$3.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.42M
5
LGM
Logos Global Management
California
+$3M

Top Sellers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
-$5.68M
2
Victory Capital Management
Victory Capital Management
Texas
-$4M
3
ECM
ExodusPoint Capital Management
New York
-$295K
4
UOC
UBS O'Connor
Illinois
-$213K
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
1
Peter Svennilson
$197M – – –
ROTUOC
2
Regents of the University of California
California
$45.6M +$30.4M +196,530 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$41.5M +$2.51M +16,228 +10%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$34.3M -$178K -1,148 -0.8%
BlackRock
5
BlackRock
New York
$33.2M +$11.7M +75,458 +112%
AI
6
Alphabet Inc
California
$24.3M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$13.3M +$3.42M +22,111 +63%
Squarepoint
8
Squarepoint
New York
$12.6M +$3.74M +24,174 +1,038%
State Street
9
State Street
Massachusetts
$5.16M +$2.97M +19,227 +637%
LGM
10
Logos Global Management
California
$4.5M +$3M +19,375 New
Northern Trust
11
Northern Trust
Illinois
$4.33M +$2.24M +14,495 +350%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$3.81M +$1.18M +7,606 +86%
Goldman Sachs
13
Goldman Sachs
New York
$2.56M +$1.71M +11,043 New
SSA
14
Schonfeld Strategic Advisors
New York
$1.65M +$1.1M +7,093 New
Charles Schwab
15
Charles Schwab
California
$1.5M +$428K +2,766 +75%
N
16
Nuveen
North Carolina
$1.39M +$928K +6,000 New
Wells Fargo
17
Wells Fargo
California
$1.23M +$561K +3,629 +217%
PHP
18
Parkman Healthcare Partners
Connecticut
$1.16M +$773K +5,000 New
PCM
19
Pentwater Capital Management
Florida
$1.06M +$23.7K +153 +3%
Millennium Management
20
Millennium Management
New York
$1.03M -$167K -1,083 -20%
Victory Capital Management
21
Victory Capital Management
Texas
$1.03M -$4M -25,846 -85%
ACM
22
Asymmetry Capital Management
California
$1.01M +$670K +4,332 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$855K +$570K +3,687 New
JP Morgan Chase
24
JP Morgan Chase
New York
$830K +$543K +3,512 +5,665%
TD Asset Management
25
TD Asset Management
Ontario, Canada
$777K +$214K +1,384 +71%
1
2 3

RAPT Hedge Fund Activity: Q2 2020 in Review

54 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q2 2020, worth a combined $443M — up 77% from $250M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RAPT positions and 4 closed out — a net gain of 16 holders — while 24 added to existing stakes and 4 trimmed.

The largest buyer was Regents of the University of California, opening a new position worth an estimated $30.4M. The largest seller was Luminus Management, exiting entirely with an estimated $5.68M sold.

  • 54 institutional investors held RAPT Therapeutics (RAPT) as of Q2 2020, up from 38 in Q1 2020.
  • Funds reported $443M of RAPT Therapeutics stock for Q2 2020, up 77% quarter-over-quarter.
  • 20 funds opened new RAPT Therapeutics positions in Q2 2020 and 4 closed out, a net change of +16 holders.
  • The largest RAPT Therapeutics buyer in Q2 2020 was Regents of the University of California, an estimated $30.4M added.
  • The largest RAPT Therapeutics seller in Q2 2020 was Luminus Management, an estimated $5.68M sold.

Based on aggregated 13F filings for Q2 2020.